 | | KXT | | Name: | 2,6-diphenylimidazo[1,2-a]pyridine | | Formula: | C19 H14 N2 | | SMILES: | c1ccc(cc1)c2ccc3nc(cn3c2)c4ccccc4 | | InChi: | InChI=1S/C19H14N2/c1-3-7-15(8-4-1)17-11-12-19-20-18(14-21(19)13-17)16-9-5-2-6-10-16/h1-14H | | Definition date: | 2019-07-03 | | Last modified: | 2020-04-17 | | Release date: | 2020-04-22 | | Identifier: | 2,6-diphenylimidazo[1,2-a]pyridine |
|
 | | KEB | | Name: | (3~{S},6~{S})-3-[(3,5-dimethyl-4-oxidanyl-phenyl)methyl]-6-[(4-hydroxyphenyl)methyl]piperazine-2,5-dione | | Formula: | C20 H22 N2 O4 | | SMILES: | Cc1cc(C[CH]2NC(=O)[CH](Cc3ccc(O)cc3)NC2=O)cc(C)c1O | | InChi: | InChI=1S/C20H22N2O4/c1-11-7-14(8-12(2)18(11)24)10-17-20(26)21-16(19(25)22-17)9-13-3-5-15(23)6-4-13/h3-8,16-17,23-24H,9-10H2,1-2H3,(H,21,26)(H,22,25)/t16-,17-/m0/s1 | | Definition date: | 2019-05-15 | | Last modified: | 2020-04-17 | | Release date: | 2020-04-22 | | Identifier: | (3~{S},6~{S})-3-[(3,5-dimethyl-4-oxidanyl-phenyl)methyl]-6-[(4-hydroxyphenyl)methyl]piperazine-2,5-dione |
|
 | | KEH | | Name: | (3~{S},6~{S})-3-[(4-hydroxyphenyl)methyl]-6-[(3-iodanyl-4-oxidanyl-phenyl)methyl]piperazine-2,5-dione | | Formula: | C18 H17 I N2 O4 | | SMILES: | Oc1ccc(C[CH]2NC(=O)[CH](Cc3ccc(O)c(I)c3)NC2=O)cc1 | | InChi: | InChI=1S/C18H17IN2O4/c19-13-7-11(3-6-16(13)23)9-15-18(25)20-14(17(24)21-15)8-10-1-4-12(22)5-2-10/h1-7,14-15,22-23H,8-9H2,(H,20,25)(H,21,24)/t14-,15-/m0/s1 | | Definition date: | 2019-05-15 | | Last modified: | 2020-04-17 | | Release date: | 2020-04-22 | | Identifier: | (3~{S},6~{S})-3-[(4-hydroxyphenyl)methyl]-6-[(3-iodanyl-4-oxidanyl-phenyl)methyl]piperazine-2,5-dione |
|
 | | KEW | | Name: | (3~{S},6~{S})-3-[(3-chloranyl-4-oxidanyl-phenyl)methyl]-6-[(4-hydroxyphenyl)methyl]piperazine-2,5-dione | | Formula: | C18 H17 Cl N2 O4 | | SMILES: | Oc1ccc(C[CH]2NC(=O)[CH](Cc3ccc(O)c(Cl)c3)NC2=O)cc1 | | InChi: | InChI=1S/C18H17ClN2O4/c19-13-7-11(3-6-16(13)23)9-15-18(25)20-14(17(24)21-15)8-10-1-4-12(22)5-2-10/h1-7,14-15,22-23H,8-9H2,(H,20,25)(H,21,24)/t14-,15-/m0/s1 | | Definition date: | 2019-05-15 | | Last modified: | 2020-04-17 | | Release date: | 2020-04-22 | | Identifier: | (3~{S},6~{S})-3-[(3-chloranyl-4-oxidanyl-phenyl)methyl]-6-[(4-hydroxyphenyl)methyl]piperazine-2,5-dione |
|
 | | D3R | | Name: | ~{tert}-butyl (2'~{R},3~{R})-2'-[3-[4-(hydroxymethyl)-3-methylsulfonyl-phenyl]phenyl]-2-oxidanylidene-spiro[1~{H}-indole-3,3'-pyrrolidine]-1'-carboxylate | | Formula: | C30 H32 N2 O6 S | | SMILES: | CC(C)(C)OC(=O)N1CC[C]2([CH]1c3cccc(c3)c4ccc(CO)c(c4)[S](C)(=O)=O)C(=O)Nc5ccccc25 | | InChi: | InChI=1S/C30H32N2O6S/c1-29(2,3)38-28(35)32-15-14-30(23-10-5-6-11-24(23)31-27(30)34)26(32)21-9-7-8-19(16-21)20-12-13-22(18-33)25(17-20)39(4,36)37/h5-13,16-17,26,33H,14-15,18H2,1-4H3,(H,31,34)/t26-,30-/m1/s1 | | Definition date: | 2019-06-19 | | Last modified: | 2020-04-17 | | Release date: | 2020-04-22 | | Identifier: | ~{tert}-butyl (2'~{R},3~{R})-2'-[3-[4-(hydroxymethyl)-3-methylsulfonyl-phenyl]phenyl]-2-oxidanylidene-spiro[1~{H}-indole-3,3'-pyrrolidine]-1'-carboxylate |
|
 | | D40 | | Name: | ~{tert}-butyl (2'~{S},3~{S})-2-oxidanylidene-2'-phenyl-spiro[1~{H}-indole-3,3'-pyrrolidine]-1'-carboxylate | | Formula: | C22 H24 N2 O3 | | SMILES: | CC(C)(C)OC(=O)N1CC[C]2([CH]1c3ccccc3)C(=O)Nc4ccccc24 | | InChi: | InChI=1S/C22H24N2O3/c1-21(2,3)27-20(26)24-14-13-22(18(24)15-9-5-4-6-10-15)16-11-7-8-12-17(16)23-19(22)25/h4-12,18H,13-14H2,1-3H3,(H,23,25)/t18-,22-/m0/s1 | | Definition date: | 2019-06-20 | | Last modified: | 2020-04-17 | | Release date: | 2020-04-22 | | Identifier: | ~{tert}-butyl (2'~{S},3~{S})-2-oxidanylidene-2'-phenyl-spiro[1~{H}-indole-3,3'-pyrrolidine]-1'-carboxylate |
|
 | | D5V | | Name: | (1S,2S,3S,4R,5R)-2-amino-4-(phenylsulfanyl)-6,8-dioxabicyclo[3.2.1]octan-3-ol | | Formula: | C12 H15 N O3 S | | SMILES: | c1ccccc1SC2C(C(N)C3OC2OC3)O | | InChi: | InChI=1S/C12H15NO3S/c13-9-8-6-15-12(16-8)11(10(9)14)17-7-4-2-1-3-5-7/h1-5,8-12,14H,6,13H2/t8-,9-,10+,11-,12-/m1/s1 | | Definition date: | 2017-10-20 | | Last modified: | 2020-04-17 | | Release date: | 2020-04-22 | | Identifier: | (1S,2S,3S,4R,5R)-2-amino-4-(phenylsulfanyl)-6,8-dioxabicyclo[3.2.1]octan-3-ol (non-preferred name) |
|
 | | D5Y | | Name: | methyl 3-(5-bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-L-alaninate | | Formula: | C8 H10 Br N3 O4 | | SMILES: | O=C1NC(C(=CN1CC(N)C(=O)OC)Br)=O | | InChi: | InChI=1S/C8H10BrN3O4/c1-16-7(14)5(10)3-12-2-4(9)6(13)11-8(12)15/h2,5H,3,10H2,1H3,(H,11,13,15)/t5-/m0/s1 | | Definition date: | 2017-10-20 | | Last modified: | 2020-04-17 | | Release date: | 2020-04-22 | | Identifier: | methyl 3-(5-bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-L-alaninate |
|
 | | D6A | | Name: | (3R,5R)-5-{3-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}pyrrolidin-3-ol | | Formula: | C13 H12 F3 N3 O2 | | SMILES: | c1cc(C(F)(F)F)ccc1c2noc(n2)C3CC(O)CN3 | | InChi: | InChI=1S/C13H12F3N3O2/c14-13(15,16)8-3-1-7(2-4-8)11-18-12(21-19-11)10-5-9(20)6-17-10/h1-4,9-10,17,20H,5-6H2/t9-,10-/m1/s1 | | Definition date: | 2017-10-20 | | Last modified: | 2020-04-17 | | Release date: | 2020-04-22 | | Identifier: | (3R,5R)-5-{3-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}pyrrolidin-3-ol |
|
 | | D6D | | Name: | (1S,2S,3S,4R,5R)-2-amino-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6,8-dioxabicyclo[3.2.1]octan-3-ol | | Formula: | C11 H20 N2 O4 | | SMILES: | OCC3CCCN3C1C2OCC(C(C1O)N)O2 | | InChi: | InChI=1S/C11H20N2O4/c12-8-7-5-16-11(17-7)9(10(8)15)13-3-1-2-6(13)4-14/h6-11,14-15H,1-5,12H2/t6-,7+,8+,9+,10-,11+/m0/s1 | | Definition date: | 2017-10-20 | | Last modified: | 2020-04-17 | | Release date: | 2020-04-22 | | Identifier: | (1S,2S,3S,4R,5R)-2-amino-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6,8-dioxabicyclo[3.2.1]octan-3-ol (non-preferred name) |
|
 | | D6S | | Name: | (1S,2S,3S,4R,5R)-2-amino-4-[benzyl(methyl)amino]-6,8-dioxabicyclo[3.2.1]octan-3-ol | | Formula: | C14 H20 N2 O3 | | SMILES: | c3cccc(CN(C1C2OC(C(N)C1O)CO2)C)c3 | | InChi: | InChI=1S/C14H20N2O3/c1-16(7-9-5-3-2-4-6-9)12-13(17)11(15)10-8-18-14(12)19-10/h2-6,10-14,17H,7-8,15H2,1H3/t10-,11-,12-,13+,14-/m1/s1 | | Definition date: | 2017-10-20 | | Last modified: | 2020-04-17 | | Release date: | 2020-04-22 | | Identifier: | (1S,2S,3S,4R,5R)-2-amino-4-[benzyl(methyl)amino]-6,8-dioxabicyclo[3.2.1]octan-3-ol (non-preferred name) |
|
 | | D6V | | Name: | 2-[(3S)-pyrrolidin-3-yl]-1H-benzimidazole | | Formula: | C11 H13 N3 | | SMILES: | c32nc(C1CNCC1)nc2cccc3 | | InChi: | InChI=1S/C11H13N3/c1-2-4-10-9(3-1)13-11(14-10)8-5-6-12-7-8/h1-4,8,12H,5-7H2,(H,13,14)/t8-/m0/s1 | | Definition date: | 2017-10-20 | | Last modified: | 2020-04-17 | | Release date: | 2020-04-22 | | Identifier: | 2-[(3S)-pyrrolidin-3-yl]-1H-benzimidazole |
|
 | | D6Y | | Name: | 3-[(5-tert-butyl-1,2-oxazol-3-yl)methyl]oxetan-3-amine | | Formula: | C11 H18 N2 O2 | | SMILES: | c1(onc(c1)CC2(N)COC2)C(C)(C)C | | InChi: | InChI=1S/C11H18N2O2/c1-10(2,3)9-4-8(13-15-9)5-11(12)6-14-7-11/h4H,5-7,12H2,1-3H3 | | Definition date: | 2017-10-20 | | Last modified: | 2020-04-17 | | Release date: | 2020-04-22 | | Identifier: | 3-[(5-tert-butyl-1,2-oxazol-3-yl)methyl]oxetan-3-amine |
|
 | | D74 | | Name: | (1R,2S,3R,4R)-3-amino-4-(3-methylphenyl)cyclopentane-1,2-diol | | Formula: | C12 H17 N O2 | | SMILES: | c2c(C1C(C(C(C1)O)O)N)cc(cc2)C | | InChi: | InChI=1S/C12H17NO2/c1-7-3-2-4-8(5-7)9-6-10(14)12(15)11(9)13/h2-5,9-12,14-15H,6,13H2,1H3/t9-,10-,11-,12-/m1/s1 | | Definition date: | 2017-10-20 | | Last modified: | 2020-04-17 | | Release date: | 2020-04-22 | | Identifier: | (1R,2S,3R,4R)-3-amino-4-(3-methylphenyl)cyclopentane-1,2-diol |
|
 | | D8A | | Name: | (1R,2S,3R,4R)-3-amino-4-cyclohexylcyclopentane-1,2-diol | | Formula: | C11 H21 N O2 | | SMILES: | C2C(C1C(C(C(C1)O)O)N)CCCC2 | | InChi: | InChI=1S/C11H21NO2/c12-10-8(6-9(13)11(10)14)7-4-2-1-3-5-7/h7-11,13-14H,1-6,12H2/t8-,9-,10-,11-/m1/s1 | | Definition date: | 2017-10-23 | | Last modified: | 2020-04-17 | | Release date: | 2020-04-22 | | Identifier: | (1R,2S,3R,4R)-3-amino-4-cyclohexylcyclopentane-1,2-diol |
|
 | | D8D | | Name: | 1-[(1R)-1-cyclohexyl-2-(methylamino)-2-oxoethyl]-L-proline | | Formula: | C14 H24 N2 O3 | | SMILES: | C1C(CCCC1)C(N2C(CCC2)C(O)=O)C(=O)NC | | InChi: | InChI=1S/C14H24N2O3/c1-15-13(17)12(10-6-3-2-4-7-10)16-9-5-8-11(16)14(18)19/h10-12H,2-9H2,1H3,(H,15,17)(H,18,19)/t11-,12+/m0/s1 | | Definition date: | 2017-10-23 | | Last modified: | 2020-04-17 | | Release date: | 2020-04-22 | | Identifier: | 1-[(1R)-1-cyclohexyl-2-(methylamino)-2-oxoethyl]-L-proline |
|
 | | D8J | | Name: | 2-amino-1,4-anhydro-2,5-dideoxy-5-[(4-fluorobenzene-1-carbonyl)amino]-D-arabinitol | | Formula: | C12 H15 F N2 O3 | | SMILES: | c1cc(F)ccc1C(=O)NCC2C(O)C(N)CO2 | | InChi: | InChI=1S/C12H15FN2O3/c13-8-3-1-7(2-4-8)12(17)15-5-10-11(16)9(14)6-18-10/h1-4,9-11,16H,5-6,14H2,(H,15,17)/t9-,10-,11+/m1/s1 | | Definition date: | 2017-10-23 | | Last modified: | 2020-04-17 | | Release date: | 2020-04-22 | | Identifier: | 2-amino-1,4-anhydro-2,5-dideoxy-5-[(4-fluorobenzene-1-carbonyl)amino]-D-arabinitol |
|
 | | D8M | | Name: | 2-[(2S,3R,4S,5R)-5-(aminomethyl)-3,4-dihydroxytetrahydrofuran-2-yl]-N-(pyridin-2-ylmethyl)acetamide | | Formula: | C13 H19 N3 O4 | | SMILES: | OC2C(CC(=O)NCc1ccccn1)OC(C2O)CN | | InChi: | InChI=1S/C13H19N3O4/c14-6-10-13(19)12(18)9(20-10)5-11(17)16-7-8-3-1-2-4-15-8/h1-4,9-10,12-13,18-19H,5-7,14H2,(H,16,17)/t9-,10+,12-,13+/m0/s1 | | Definition date: | 2017-10-23 | | Last modified: | 2020-04-17 | | Release date: | 2020-04-22 | | Identifier: | 2-[(2S,3R,4S,5R)-5-(aminomethyl)-3,4-dihydroxytetrahydrofuran-2-yl]-N-(pyridin-2-ylmethyl)acetamide (non-preferred name) |
|
 | | D8P | | Name: | [(2S)-1,9-dimethyl-1,2,3,4,5,6-hexahydropyrido[2,3-b][1,5]diazocin-2-yl]methanol | | Formula: | C12 H19 N3 O | | SMILES: | c21CNCCC(N(c1nc(cc2)C)C)CO | | InChi: | InChI=1S/C12H19N3O/c1-9-3-4-10-7-13-6-5-11(8-16)15(2)12(10)14-9/h3-4,11,13,16H,5-8H2,1-2H3/t11-/m0/s1 | | Definition date: | 2017-10-23 | | Last modified: | 2020-04-17 | | Release date: | 2020-04-22 | | Identifier: | [(2S)-1,9-dimethyl-1,2,3,4,5,6-hexahydropyrido[2,3-b][1,5]diazocin-2-yl]methanol |
|
 | | D8V | | Name: | 4-(2-{[methyl(prop-2-yn-1-yl)amino]methyl}-1,3-thiazol-4-yl)piperidin-4-ol | | Formula: | C13 H19 N3 O S | | SMILES: | C(N(C)CC#C)c2nc(C1(CCNCC1)O)cs2 | | InChi: | InChI=1S/C13H19N3OS/c1-3-8-16(2)9-12-15-11(10-18-12)13(17)4-6-14-7-5-13/h1,10,14,17H,4-9H2,2H3 | | Definition date: | 2017-10-23 | | Last modified: | 2020-04-17 | | Release date: | 2020-04-22 | | Identifier: | 4-(2-{[methyl(prop-2-yn-1-yl)amino]methyl}-1,3-thiazol-4-yl)piperidin-4-ol |
|
 | | D97 | | Name: | (1S,2S,3S,4R,5R)-4-(morpholin-4-yl)-2-[(quinolin-3-ylmethyl)amino]-6,8-dioxabicyclo[3.2.1]octan-3-ol | | Formula: | C20 H25 N3 O4 | | SMILES: | O5CCN(C3C4OCC(C(NCc1cc2c(nc1)cccc2)C3O)O4)CC5 | | InChi: | InChI=1S/C20H25N3O4/c24-19-17(22-11-13-9-14-3-1-2-4-15(14)21-10-13)16-12-26-20(27-16)18(19)23-5-7-25-8-6-23/h1-4,9-10,16-20,22,24H,5-8,11-12H2/t16-,17-,18-,19+,20-/m1/s1 | | Definition date: | 2017-10-23 | | Last modified: | 2020-04-17 | | Release date: | 2020-04-22 | | Identifier: | (1S,2S,3S,4R,5R)-4-(morpholin-4-yl)-2-[(quinolin-3-ylmethyl)amino]-6,8-dioxabicyclo[3.2.1]octan-3-ol (non-preferred name) |
|
 | | D9D | | Name: | (1S,2S,3S,4R,5R)-2-({[5-(hydroxymethyl)furan-2-yl]methyl}amino)-4-(morpholin-4-yl)-6,8-dioxabicyclo[3.2.1]octan-3-ol | | Formula: | C16 H24 N2 O6 | | SMILES: | OC2C(C3COC(C2N1CCOCC1)O3)NCc4oc(CO)cc4 | | InChi: | InChI=1S/C16H24N2O6/c19-8-11-2-1-10(23-11)7-17-13-12-9-22-16(24-12)14(15(13)20)18-3-5-21-6-4-18/h1-2,12-17,19-20H,3-9H2/t12-,13-,14-,15+,16-/m1/s1 | | Definition date: | 2017-10-23 | | Last modified: | 2020-04-17 | | Release date: | 2020-04-22 | | Identifier: | (1S,2S,3S,4R,5R)-2-({[5-(hydroxymethyl)furan-2-yl]methyl}amino)-4-(morpholin-4-yl)-6,8-dioxabicyclo[3.2.1]octan-3-ol (non-preferred name) |
|
 | | D9M | | Name: | (1S,2S,3S,4R,5R)-4-(morpholin-4-yl)-2-[(pyridin-4-ylmethyl)amino]-6,8-dioxabicyclo[3.2.1]octan-3-ol | | Formula: | C16 H23 N3 O4 | | SMILES: | O1CCN(CC1)C3C4OCC(C(NCc2ccncc2)C3O)O4 | | InChi: | InChI=1S/C16H23N3O4/c20-15-13(18-9-11-1-3-17-4-2-11)12-10-22-16(23-12)14(15)19-5-7-21-8-6-19/h1-4,12-16,18,20H,5-10H2/t12-,13-,14-,15+,16-/m1/s1 | | Definition date: | 2017-10-23 | | Last modified: | 2020-04-17 | | Release date: | 2020-04-22 | | Identifier: | (1S,2S,3S,4R,5R)-4-(morpholin-4-yl)-2-[(pyridin-4-ylmethyl)amino]-6,8-dioxabicyclo[3.2.1]octan-3-ol (non-preferred name) |
|
 | | D9S | | Name: | 2-{(3R,4S)-3-[(5-{[benzyl(methyl)amino]methyl}-1,2-oxazol-3-yl)methyl]piperidin-4-yl}-N-(1,3-thiazol-2-yl)acetamide | | Formula: | C23 H29 N5 O2 S | | SMILES: | c1cc(ccc1)CN(Cc2cc(no2)CC3CNCCC3CC(Nc4nccs4)=O)C | | InChi: | InChI=1S/C23H29N5O2S/c1-28(15-17-5-3-2-4-6-17)16-21-13-20(27-30-21)11-19-14-24-8-7-18(19)12-22(29)26-23-25-9-10-31-23/h2-6,9-10,13,18-19,24H,7-8,11-12,14-16H2,1H3,(H,25,26,29)/t18-,19-/m0/s1 | | Definition date: | 2017-10-23 | | Last modified: | 2020-04-17 | | Release date: | 2020-04-22 | | Identifier: | 2-{(3R,4S)-3-[(5-{[benzyl(methyl)amino]methyl}-1,2-oxazol-3-yl)methyl]piperidin-4-yl}-N-(1,3-thiazol-2-yl)acetamide |
|
 | | D9V | | Name: | (1S,2S,3S,4R,5R)-2-[(furan-2-ylmethyl)amino]-4-(piperidin-1-yl)-6,8-dioxabicyclo[3.2.1]octan-3-ol | | Formula: | C16 H24 N2 O4 | | SMILES: | OC3C(NCc1occc1)C4COC(C3N2CCCCC2)O4 | | InChi: | InChI=1S/C16H24N2O4/c19-15-13(17-9-11-5-4-8-20-11)12-10-21-16(22-12)14(15)18-6-2-1-3-7-18/h4-5,8,12-17,19H,1-3,6-7,9-10H2/t12-,13-,14-,15+,16-/m1/s1 | | Definition date: | 2017-10-23 | | Last modified: | 2020-04-17 | | Release date: | 2020-04-22 | | Identifier: | (1S,2S,3S,4R,5R)-2-[(furan-2-ylmethyl)amino]-4-(piperidin-1-yl)-6,8-dioxabicyclo[3.2.1]octan-3-ol (non-preferred name) |
|